180 related articles for article (PubMed ID: 11383716)
1. Effects of Ro 64-6198 in nociceptin/orphanin FQ-sensitive isolated tissues.
Rizzi D; Bigoni R; Rizzi A; Jenck F; Wichmann J; Guerrini R; Regoli D; Calo G
Naunyn Schmiedebergs Arch Pharmacol; 2001 May; 363(5):551-5. PubMed ID: 11383716
[TBL] [Abstract][Full Text] [Related]
2. In vitro pharmacological profile of peptide III-BTD: a novel ligand for nociceptin/orphanin FQ and opioid receptors.
Bigoni R; Rizzi A; Rizzi D; Becker JA; Kieffer BL; Simonin F; Regoli D; Calo G
Life Sci; 2000 Dec; 68(2):233-9. PubMed ID: 11191640
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of nociceptin receptor: an in vitro study.
Calò G; Rizzi A; Bodin M; Neugebauer W; Salvadori S; Guerrini R; Bianchi C; Regoli D
Can J Physiol Pharmacol; 1997 Jun; 75(6):713-8. PubMed ID: 9276153
[TBL] [Abstract][Full Text] [Related]
4. [Arg(14),Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies.
Rizzi D; Rizzi A; Bigoni R; Camarda V; Marzola G; Guerrini R; De Risi C; Regoli D; Calo' G
J Pharmacol Exp Ther; 2002 Jan; 300(1):57-63. PubMed ID: 11752097
[TBL] [Abstract][Full Text] [Related]
5. In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist.
Bigoni R; Calo' G; Rizzi A; Guerrini R; De Risi C; Hashimoto Y; Hashiba E; Lambert DG; Regoli D
Naunyn Schmiedebergs Arch Pharmacol; 2000 May; 361(5):565-8. PubMed ID: 10832612
[TBL] [Abstract][Full Text] [Related]
6. Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors.
Bigoni R; Caò G; Rizzi A; Okawa H; Regoli D; Smart D; Lambert DG
Can J Physiol Pharmacol; 2002 May; 80(5):407-12. PubMed ID: 12056546
[TBL] [Abstract][Full Text] [Related]
7. A new selective antagonist of the nociceptin receptor.
Guerrini R; Calo G; Rizzi A; Bigoni R; Bianchi C; Salvadori S; Regoli D
Br J Pharmacol; 1998 Jan; 123(2):163-5. PubMed ID: 9489602
[TBL] [Abstract][Full Text] [Related]
8. Effects of nociceptin and endomorphin 1 on the electrically stimulated human vas deferens.
Bigoni R; Calo G; Guerrini R; Strupish JW; Rowbotham DJ; Lambert DG
Br J Clin Pharmacol; 2001 Apr; 51(4):355-8. PubMed ID: 11318773
[TBL] [Abstract][Full Text] [Related]
9. In vitro agonist effects of nociceptin and [Phe(1)psi(CH(2)-NH)Gly(2)]nociceptin(1-13)NH(2) in the mouse and rat colon and the mouse vas deferens.
Menzies JR; Glen T; Davies MR; Paterson SJ; Corbett AD
Eur J Pharmacol; 1999 Dec; 385(2-3):217-23. PubMed ID: 10607879
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of [Tyr1]nociceptin analogs: receptor binding and bioassay studies.
Varani K; Rizzi A; Calo G; Bigoni R; Toth G; Guerrini R; Gessi S; Salvadori S; Borea PA; Regoli D
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):270-7. PubMed ID: 10543428
[TBL] [Abstract][Full Text] [Related]
11. Novel potent agonist [(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 and antagonist [Nphe1,(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 of nociceptin/orphanin FQ receptor.
Peng YL; Chang M; Dong SL; Li W; Han RW; Fu GX; Chen Q; Wang R
Regul Pept; 2006 May; 134(2-3):75-81. PubMed ID: 16516988
[TBL] [Abstract][Full Text] [Related]
12. Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies.
Bigoni R; Giuliani S; Calo' G; Rizzi A; Guerrini R; Salvadori S; Regoli D; Maggi CA
Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):160-7. PubMed ID: 10208302
[TBL] [Abstract][Full Text] [Related]
13. Characterisation and comparison of novel ligands for the nociceptin/orphanin FQ receptor.
Hashiba E; Harrison C; Galo' G; Guerrini R; Rowbotham DJ; Smith G; Lambert DG
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):28-33. PubMed ID: 11191833
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)NH2 in rat brain, rat vas deferens and CHO cells expressing recombinant human nociceptin receptors.
Okawa H; Nicol B; Bigoni R; Hirst RA; Calo G; Guerrini R; Rowbotham DJ; Smart D; McKnight AT; Lambert DG
Br J Pharmacol; 1999 May; 127(1):123-30. PubMed ID: 10369464
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship of [Nphe1]-NC-(1-13)-NH2, a pure and selective nociceptin/orphanin FQ receptor antagonist.
Guerrini R; Calo' G; Bigoni R; Rizzi D; Regoli D; Salvadori S
J Pept Res; 2001 Mar; 57(3):215-22. PubMed ID: 11298922
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of the cyclic nociceptin/orphanin FQ analogues c[Cys10,14]N/OFQ(1-14)NH2 and c[Nphe1,Cys10,14]N/OFQ(1-14)NH2.
Kitayama M; Barnes TA; Carra G; McDonald J; Calo G; Guerrini R; Rowbotham DJ; Smith G; Lambert DG
Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):528-37. PubMed ID: 14598020
[TBL] [Abstract][Full Text] [Related]
17. Further characterization of the prototypical nociceptin/orphanin FQ peptide receptor agonist Ro 64-6198 in rodent models of conflict anxiety and despair.
Goeldner C; Spooren W; Wichmann J; Prinssen EP
Psychopharmacology (Berl); 2012 Jul; 222(2):203-14. PubMed ID: 22249359
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studies.
Spagnolo B; Carrà G; Fantin M; Fischetti C; Hebbes C; McDonald J; Barnes TA; Rizzi A; Trapella C; Fanton G; Morari M; Lambert DG; Regoli D; Calò G
J Pharmacol Exp Ther; 2007 Jun; 321(3):961-7. PubMed ID: 17329552
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor.
Rizzi A; Spagnolo B; Wainford RD; Fischetti C; Guerrini R; Marzola G; Baldisserotto A; Salvadori S; Regoli D; Kapusta DR; Calo G
Peptides; 2007 Jun; 28(6):1240-51. PubMed ID: 17532097
[TBL] [Abstract][Full Text] [Related]
20. Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor.
Guerrini R; Caló G; Bigoni R; Rizzi A; Varani K; Toth G; Gessi S; Hashiba E; Hashimoto Y; Lambert DG; Borea PA; Tomatis R; Salvadori S; Regoli D
J Med Chem; 2000 Jul; 43(15):2805-13. PubMed ID: 10956188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
